Nautilus Biotechnology, Inc.
NASDAQ:NAUT
2.61 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 5.705 | 3.416 | 2.842 | 2.346 | 0 | 0 |
Gross Profit
| -5.705 | -3.416 | -2.842 | -2.346 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 47.251 | 37.672 | 29.352 | 12.432 | 0.008 | 0 |
General & Administrative Expenses
| 28.901 | 25.946 | 21.146 | 3.312 | 0.002 | 111.684 |
Selling & Marketing Expenses
| -3.856 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 28.901 | 25.946 | 21.146 | 3.312 | 0.002 | 111.684 |
Other Expenses
| 0 | -0.122 | 0.183 | 0.125 | 0 | 0 |
Operating Expenses
| 76.152 | 63.618 | 50.498 | 15.744 | 0.01 | 111.684 |
Operating Income
| -76.152 | -63.618 | -50.498 | -15.744 | -0.01 | -111.684 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 12.477 | 5.694 | 0.183 | 0.125 | 0 | 738.284 |
Income Before Tax
| -63.675 | -57.924 | -50.315 | -15.619 | -0.01 | 626.6 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 5.816 | 2.605 | 2.14 | -0.171 | 738.123 |
Net Income
| -63.675 | -63.74 | -50.315 | -15.619 | -0.01 | 626.6 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.51 | -0.51 | -0.6 | -0.52 | -0.001 | 87.18 |
EPS Diluted
| -0.51 | -0.51 | -0.6 | -0.52 | -0.001 | 87.18 |
EBITDA
| -74.303 | -60.202 | -47.656 | -13.398 | -0.01 | 626.6 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |